WHO SHOULD BE INVOLVED

Within industry the principal actors representing the technical, managerial and financial functions must collaborate actively if Life Cycle Engineering practices are to be implemented. Change cannot be undertaken by a single group alone, as its effects go far beyond any one function s activities. This collaboration should occur as early as possible during product development. 

Each employee of a corporation is also, of course, a member of society and as such he or she must reconcile personal views on environmental change with LCE practice. The commitment of management within a corporation to Life Cycle Engineering is a necessary, but not sufficient, condition for ensuring its acceptance at all levels of the company. Environmental change within the corporation cannot occur if it proves to be out of phase with change in society. 

Increased public attention to environmental issues has brought about rapid change in legislation and in consumer patterns, with immediate consequences for industrial activities. The response of organisations can take one of three possible forms  

Steadily increasing fines for non-compliance with laws and rocketing charges for dumping waste make the first alternative highly risky. The difficulty in following the second option was expressed by G.V. Cox of the Chemical Manufacturers Association [25]  

Meadows, D. H. Meadows, J. Randers, and W. B. Behrens, The Limits to Growth Report to the Club of Rome s Project on the Predicament of Mankind, Potomac Associates, Universe Books New York, USA (1972). 

---

This section provides information on the personnel who should be involved in data collection and the design of reporting forms. The specific data needs for major incident analyses are discussed, together with the storage and retrieval of data for the purpose of analysis. 

We could put it more generally and say that each object can initiate actions with one or more other objects. You may know what you need to achieve and who should be involved, but you may not care (yet) how it is to be achieved or who should be primarily responsible for each part. 

Who should be involved in designing job evaluation The choice is usually among compensation professionals, managers, and/or job incumbents. If job evaluation is to be an aid to managers and if... 

In Chapter 8, we begin to consider relationship building. Initially, we will look at relationships from maity perspectives. It is important to determine who should be involved, how teams should be arranged, and the scope of the work that the teams can do. 

To be effective and timely, an assessment should be part of an overall strategy scheduled into your annual planning process. The assessment can be spread over time to make use of available windows of opportunity given all the other activities that must be completed by the leadership and employees who should be involved. 

Who writes the rules A recurring theme in the chapters is the issue of who should be involved in writing or agreeing the rules which will be used as the basis for regulation. A number of variants were described in different areas of safety regulation, some related to product safety, and others to medical safety, or avoidance of industrial injury ... 

Usually, before deciding who should be involved, you will have to decide what work areas are to participate. If you work in a large organization or at a large site, consider whether to pilot your behavioral process. A pilot is a good idea if your organization is likely to be particularly resistant to the idea. Most employees should view the pilot areas as representative of the organization, and it should usually have... 

The reader is referred to the original papers for detailed analysis, where the various components of entropy generation and irreversibility are defined. The advantage of this work is not only that it involves less approximation but also that it is revealing in terms of the basic thermodynamics. It should also be used by designers who should be able to see how design changes relate to increased or decreased local loss. 

HRT is indicated primarily for the relief of moderate to severe vasomotor symptoms. It remains the most effective treatment for vasomotor symptoms and should be considered only in women experiencing those symptoms. Women with mild vasomotor symptoms may benefit from nonpharmacologic therapy alone however, many women will seek medical treatment for these symptoms. The benefits of HRT outweigh the risks in women who do not have CHD or CHD and breast cancer risk factors however, careful consideration should be given to alternative therapies for the relief of menopausal symptoms in women with these risks. Women should be involved in the decision and may choose to use HRT despite having some risk factors owing to the severity of their symptoms. Regardless of the situation, HRT should be prescribed at the lowest dose that relieves or reduces menopausal symptoms and should be recommended only for short-term use. Women should be reassessed every 6 to 12 months, and discontinuation of therapy should be considered. 

From many companies perspectives, classification by severity is the most common classification system used to establish when to investigate an incident and who should be on a team. The main disadvantage with using severity alone to establish team membership is that it does not consider the potential loss from the occurrence, such as that with a high potential incident. In addition, the complexity of the system involved should also be used to determine team composition as more complex systems might require a larger team to understand the data. 

A protocol for the first and other early studies with a NME in man is similar to those for later studies in healthy volunteers and patients but has some particular features that are worth special consideration. The protocol should be written to satisfy not only the needs of regulatory authorities and personnel who will be involved in conduct of the study but also to facilitate the work of the lEC, which bears considerable responsibility in such cases. The nature of the scientific material contained in the protocol is often complex, highly specialised and quite unlike most protocols for clinical trials handled by such committees. 

The pharmaceutical physician should be involved in the selection of CROs and SMOs. He or she is often best qualified to judge the professional competency of the physicians involved in any contractual work. There needs to be a clear imderstanding as to who will provide medical advice to the investigator and to the nonphysicians in the clinical trial teams, who will be responsible for the assessment of the medical... 

Koehn then discussed the idea of intramural funding, which he described as monies mobilized, identified, and deployed by an institution for a specific purpose. He offered examples of intramural funding projects on the university level and methods to make these projects more lucrative. Koehn believes that closer tracking of technology transfer will increase the commercialization of products. In addition, those who invest funds and seek a return on their funds should be involved in management decisions about projects. Lastly, these programs must be responsive to faculty and encourage partnerships between investors and scientists. 

Dr. Robert Bradley introduced the husband/partner into the birthing room. He believed that the partner could and should be involved in the labor and birth. The Bradley classes call the partners coaches, and there is a heavy (some might say intense) emphasis on birthing without medication. A downside is that women who have studied this method, and for whatever reason go on to have to have a medicated birth or a C-section, often report feeling like they failed at childbirth. Couples interested in Bradley might want to supplement their classes with reading about pain medication just in case. For more information visit www.bradleybirth.com. 

An important issue on multiauthored papers is deciding who should be an author (single-authored empirical reports are extremely rare since contemporary clinical research typically requires considerable collaboration). Since many people are involved in the execution of a clinical trial, appropriate criteria are needed to decide on those who will be listed as authors. As in so many instances in this book, both scientific and ethical issues need to be addressed. It is unethical for someone who should not be an author to expect to be so. 

The second difficulty with process claims for new uses of an old chemical is Who should be sued That is How can the patent be enforced If a patent issues on a method of treatment involving the administration of an old substance as a medicine, is the actual infringer the physician or the patient Is the answer different if the patient is an adult, a baby, or an animal If the use is of an insecticide, the infringer is the farmer. If the patentee must file a separate suit for each patient or farmer, he may have a perfectly valid cause of action but it is illusory protection as it is difficult to catch each separate infringer and if he does, the recovery from each could be mockingly small. 

I gratefully acknowledge the constructive and fruitful cooperation which has been very active between Orsay and several laboratories in physics and chemistry all over Europe, Quebec, and South Korea. The list of colleagues and co-workers who have been involved in the research on molecular superconductors is so long that I would rather refer the reader to the reference list, where the names of colleagues who should be thanked for their cooperation can easily be found. This research has been supported partially by EEC Esprit Basic Research Action 3121, Stimulation Program CI-CT 90-0863 at DG XII, DRET contract 88/198, and CNRS-GDR Qo-... 

Goals may be set for each duty or project assigned. They may be set for activities or behaviors that apply to many assignments or projects (e.g., computer work or cooperation). It is important that everyone who will be involved in evaluating an employee s performance is clear about which aspects of the employee s performance will be evaluated and what successful performance will look like. You should be able to match outcome-based criteria in the job description, project assignment, or both, directly to the evaluation criteria in the performance evaluation instrument. 

Who Should Develop Immunoassays The answer to this question is simple - everyone. The more complex question is once these assays are developed how do we get them in the hands of users Certainly the agricultural chemical industry should be involved in the development of assays for their products. Even if the assays are never used for registration, the assays will save companies money by being used in-house as research tools. In most companies there is such a backlog of residue samples to run that in-house assays to test formulation, plant distribution, process control and many other problems receive low priority. Immunoassays can have a major impact on these problems. 

The worksheet lists the same 21 service categories addressed by the sponsor in the study specifications worksheet. For each category, the bidder should list the types of personnel who will be involved in performing that service. For each type of personnel, the CRO should define the number of hours/FTEs, the rate charged per unit of time and the total cost for that person to perform that service. 

---